Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts

Julia Ballouhey, Lara Landès, Jean-Yves Grolleau, François Dalmay, Boris Melloni
European Respiratory Journal 2013 42: P2845; DOI:
Julia Ballouhey
1Committee of Fight Against Tuberculosis, CHU Limoges, Limoges, France
2Pulmonary Diseases Department, CHU Limoges, Limoges, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lara Landès
2Pulmonary Diseases Department, CHU Limoges, Limoges, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Yves Grolleau
2Pulmonary Diseases Department, CHU Limoges, Limoges, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Dalmay
3Medical Biostatistics, CHU Limoges, Limoges, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris Melloni
1Committee of Fight Against Tuberculosis, CHU Limoges, Limoges, France
2Pulmonary Diseases Department, CHU Limoges, Limoges, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Recently, interferon-gamma release assay are used to discriminate potential infection and prior vaccination with BCG. The aim of this study was to compare the level of agreement between TST and Quantiferon-TB Gold in tube assay (QFT) in exposed contacts of active tuberculosis in a French area with TB low incidence and in immigrants from countries of high incidence. A total of 837 adults (mean age, 36 years) exposed to LTBI by recent contact or recent migrants were enrolled. TST was considered positive with a cut-off of 10mm and QFT test was positive for a cut-off 0.35 IU/ml. In all population (n=837), 413 subjects (49%) had a positive TST result and 251(30%) had a positive QFT result with a kappa concordance test: 0,32. In recent migrants from North or sub-Saharan Africa or ex-USSR (n=451), 137 (43%) participants had a positive TST and 194 (39%) had positive QFT result, with Kappa concordance test of 0,56. In recent TB contact participants, 195 (58%) had a positive TST and 64 (19%) had a positive QFT result with a Kappa concordance test of 0.08. Overall agreement between the TST and QFT was significant only in immigrants from area with high prevalence of TB. In TB contact subjects, the low concordance is explained by prior BCG vaccination in French population. Our study is limited to one-centre recruitment but it is pertinent to compare subjects from low to high incidence area of TB. Published studies are confirmed the advantage of interferon-gamma release assays over the TST to detect latent TB infection. Nevertheless, prior BCG vaccination and patient origin from low or high prevalence countries could be specified.

  • IGRA (Interferon γ)
  • Tuberculosis - diagnosis
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Julia Ballouhey, Lara Landès, Jean-Yves Grolleau, François Dalmay, Boris Melloni
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2845;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Julia Ballouhey, Lara Landès, Jean-Yves Grolleau, François Dalmay, Boris Melloni
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2845;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Two case reports: The successful management of pulmonary mycobacterium bohemicum
  • Vitamin D binding protein (DBP) levels during tuberculosis treatment are affected by DBP genotype / haplotype but not by total vitamin D levels
  • Monitoring of adverse events of BCG vaccination in Moscow, Russia
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society